[New therapies for spastic movement disorders]

MeSH terms

• Administration, Oral
• Baclofen / adverse effects
• Baclofen / therapeutic use
• Botulinum Toxins, Type A / adverse effects
• Botulinum Toxins, Type A / therapeutic use
• Cannabinoids / adverse effects
• Cannabinoids / therapeutic use
• Clonidine / adverse effects
• Clonidine / analogs & derivatives
• Clonidine / therapeutic use
• Diazepam / adverse effects
• Diazepam / therapeutic use
• Humans
• Injections, Intramuscular
• Injections, Spinal
• Movement Disorders / etiology
• Movement Disorders / rehabilitation*
• Muscle Relaxants, Central / adverse effects
• Muscle Relaxants, Central / therapeutic use
• Muscle Spasticity / etiology
• Muscle Spasticity / rehabilitation*
• Parasympatholytics / adverse effects
• Parasympatholytics / therapeutic use
• Physical Therapy Modalities
• Tolperisone / adverse effects
• Tolperisone / therapeutic use